Clinical Trials

Showing trials with last updates posted in 2026.

NCT03025256 | ACTIVE_NOT_RECRUITING | PHASE1
75 participants

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2018-05-02
Completion:
2027-06-01
Conditions
  • Acral Lentiginous Melanoma
  • Central Nervous System Melanoma
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Leptomeningeal Neoplasm
  • Melanocytoma
  • Metastatic Lung Non-Small Cell Carcinoma
  • Metastatic Melanoma
  • Metastatic Mucosal Melanoma
  • Metastatic Uveal Melanoma
  • Stage IV Lung Cancer AJCC v8
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT03007147 | ACTIVE_NOT_RECRUITING | PHASE3
352 participants

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2017-08-08
Completion:
2026-06-30
Conditions
  • Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia
  • Mixed Phenotype Acute Leukemia
  • T Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT02734537 | RECRUITING | PHASE2
189 participants

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2016-11-23
Completion:
2027-12-31
Conditions
  • Head and Neck Squamous Cell Carcinoma
  • Hypopharyngeal Squamous Cell Carcinoma
  • Laryngeal Squamous Cell Carcinoma
  • Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant
  • Lip and Oral Cavity Squamous Cell Carcinoma
  • p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
  • Stage III Hypopharyngeal Carcinoma AJCC v8
  • Stage III Laryngeal Cancer AJCC v8
  • Stage III Lip and Oral Cavity Cancer AJCC v8
  • Stage III Oral Cavity Verrucous Carcinoma
  • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage IVA Hypopharyngeal Carcinoma AJCC v8
  • Stage IVA Laryngeal Cancer AJCC v8
  • Stage IVA Lip and Oral Cavity Cancer AJCC v8
  • Stage IVA Oral Cavity Verrucous Carcinoma
  • Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
  • DRUG
  • RADIATION
  • OTHER
No Results Yet
NCT02689440 | ACTIVE_NOT_RECRUITING | PHASE2
155 participants

Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2016-02-19
Completion:
2040-12-31
Conditions
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT02223208 | COMPLETED | PHASE1/PHASE2
89 participants

Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2014-09-30
Completion:
2020-10-31
Conditions
  • Peripheral T-cell Lymphomas (PTCL)
  • PTCL-NOS
  • Angioimmunoblastic T-cell Lymphoma (AITL)
  • ALK- Anaplastic Large Cell Lymphoma (ALCL)
  • Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page